Subsequently, studies examining mutant p53 in pancreatic cancer have indicated that mutant p53 cannot inhibit pancreatic cancer progression but correlates with lymph node metastasis and upregulated PDGF receptor β signaling, which stimulate pancreatic cancer cell invasion in vitro and metastasis formation in vivo. This evidence concerns the gene TP53 and pancreatic neoplasm.